CIK 0001598646 · Non-accelerated filer<br>Smaller reporting company
Minerva Neurosciences, Inc.
Sign in to watch- Ticker
- NERV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 260784194
- Phone
- 617-600-7373
- Business address
- 1500 DISTRICT AVENUE, BURLINGTON, MA, 01803
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-11 | Kupfer David Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2020-12-16 | Reilly Joseph H. SVP & Chief Operating Officer | Sale | −3,228 | $2.64 | $9K | 31,747 |
| 2020-12-16 | Race Geoff EVP, CFO & CBO | Sale | −6,190 | $2.64 | $16K | 211,354 |
| 2020-12-16 | Luthringer Remy CEO | Sale | −1,300 | $2.64 | $3K | 66,490 |
| 2020-12-16 | Ahlholm Frederick W SVP, Chief Accounting Officer | Sale | −1,845 | $2.64 | $5K | 10,039 |
| 2020-12-14 | Reilly Joseph H. SVP & Chief Operating Officer | Option exercise | +8,750 | 34,975 | ||
| 2020-12-14 | Reilly Joseph H. SVP & Chief Operating Officer | Option exercise · Restricted Stock Unit | −8,750 | 0 | ||
| 2020-12-14 | Race Geoff EVP, CFO & CBO | Option exercise | +12,500 | 217,544 | ||
| 2020-12-14 | Race Geoff EVP, CFO & CBO | Option exercise · Restricted Stock Unit | −12,500 | 0 | ||
| 2020-12-14 | Luthringer Remy CEO | Option exercise | +18,750 | 67,790 | ||
| 2020-12-14 | Luthringer Remy CEO | Option exercise · Restricted Stock Unit | −18,750 | 0 | ||
| 2020-12-14 | Ahlholm Frederick W SVP, Chief Accounting Officer | Option exercise | +5,000 | 11,884 | ||
| 2020-12-14 | Ahlholm Frederick W SVP, Chief Accounting Officer | Option exercise · Restricted Stock Unit | −5,000 | 0 | ||
| 2020-10-13 | Smith Devin Whittemore SVP and General Counsel | Grant or award · Employee Stock Option (right to buy) | +85,000 | 85,000 | ||
| 2020-10-13 | Race Geoff EVP, CFO & CBO | Grant or award · Employee Stock Option (right to buy) | +140,000 | 140,000 | ||
| 2020-10-13 | Luthringer Remy CEO | Grant or award · Employee Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2020-10-13 | Davidson Michael Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +85,000 | 85,000 | ||
| 2020-10-13 | Reilly Joseph H. SVP & Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +85,000 | 85,000 | ||
| 2020-10-13 | Ahlholm Frederick W SVP, Chief Accounting Officer | Grant or award · Employee Stock Option (right to buy) | +85,000 | 85,000 | ||
| 2020-10-13 | Saoud Jay SVP and Head of R&D | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 |
Page 4 of 6 · 120 trades